Segovia, Gregorio <br/><br/>
Effects of CB1 cannabinoid receptor modulating compounds on the hyperkinesia induced by high-dose levodopa in the reserpine-treated rat model of Parkinson's disease.  [electronic resource] 

 -  Movement disorders : official journal of the Movement Disorder Society  Feb 2003 
 - 138-49 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0885-3185 
<br/><br/><label>Standard No.: </label>10.1002/mds.10312  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adrenergic Uptake Inhibitors--therapeutic use<br/>Animals<br/>Antiparkinson Agents--administration & dosage<br/>Behavior, Animal--drug effects<br/>Cannabinoid Receptor Modulators<br/>Disease Models, Animal<br/>Dose-Response Relationship, Drug<br/>Fatty Acids, Unsaturated--pharmacology<br/>Hyperkinesis--chemically induced<br/>Levodopa--administration & dosage<br/>Male<br/>Parkinson Disease--drug therapy<br/>Rats<br/>Rats, Sprague-Dawley<br/>Receptors, Cannabinoid<br/>Receptors, Drug--drug effects<br/>Reserpine--therapeutic use<br/>Time Factors